PNV Insider Trading

Insider Ownership Percentage: 11.34%
Insider Buying (Last 12 Months): A$101,212.77
Insider Selling (Last 12 Months): A$0.00

PolyNovo Insider Trading History Chart

This chart shows the insider buying and selling history at PolyNovo by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

PolyNovo Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 05/12/2020 01:00 AM ET

This chart shows the closing price history over time for PNV up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

PolyNovo Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/31/2023Robyn ElliottInsiderBuy32,000A$1.19A$38,080.00
6/28/2023Robyn ElliottInsiderBuy27,000A$1.47A$39,690.00
6/7/2023David WilliamsInsiderBuy14,453A$1.62A$23,442.77
3/22/2023David WilliamsInsiderSell227,653A$2.04A$465,322.73
3/20/2023David WilliamsInsiderSell305,451A$2.07A$632,589.02
3/17/2023David WilliamsInsiderSell4,000,000A$2.04A$8,160,000.00
2/16/2023Bruce RathieInsiderBuy200,000A$1.90A$380,000.00
10/14/2022David WilliamsInsiderBuy42,527A$1.69A$71,700.52
10/12/2022David WilliamsInsiderBuy95,000A$1.70A$161,025.00
10/10/2022David WilliamsInsiderBuy115,000A$1.72A$198,145.00
6/6/2022David WilliamsInsiderBuy228,544A$1.14A$259,854.53
6/3/2022David WilliamsInsiderBuy266,514A$1.19A$317,418.17
5/23/2022David WilliamsInsiderBuy300,000A$1.25A$375,900.00
5/18/2022David WilliamsInsiderBuy346,193A$1.24A$430,317.90
5/16/2022David WilliamsInsiderBuy405,911A$1.27A$514,289.24
5/13/2022David WilliamsInsiderBuy181,532A$1.28A$231,453.30
5/11/2022David WilliamsInsiderBuy249,996A$1.06A$265,995.74
5/9/2022David WilliamsInsiderBuy250,000A$0.91A$227,500.00
5/5/2022David WilliamsInsiderBuy500,000A$0.87A$434,500.00
See Full Table

SEC Filings (Institutional Ownership Changes) for PolyNovo (ASX:PNV)

13.40% of PolyNovo stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

PolyNovo logo
PolyNovo Limited develops medical devices in the United States, Australia, New Zealand, the United Kingdom, Ireland, Singapore, and internationally. The company offers NovoSorb Biodegradable Temporising Matrix, which is used in a fully debrided clean surgical wound to physiologically close the wound. It is also developing hernia devices for hernia repair and solution for ventral hernia and complex abdominal wall reconstruction; NovoSorb Dermal Beta Cell Implant to host pancreatic islet cells in the skin; NovoSorb MTX for the treatment of varying complex wounds; and plastics and reconstructive device product. The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014. PolyNovo Limited was incorporated in 1998 and is headquartered in Port Melbourne, Australia.
Read More on PolyNovo

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

3,381,387 shs

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

6.86%

Beta

1.61

Who are the company insiders with the largest holdings of PolyNovo?

PolyNovo's top insider investors include:
  1. Bruce Rathie (Insider)
  2. David Williams (Insider)
  3. Robyn Elliott (Insider)
Learn More about top insider investors at PolyNovo.